2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol | |
---|---|
Trade Name | Epidiolex |
Orphan Indication | Lennox-Gastaut syndrome |
USA Market Approval | USA |
USA Designation Date | 2014-02-27 00:00:00 |
Sponsor | GW Pharma Ltd.;Porton Down Science Park, Salisbury, Wiltshire SP4 OJQ; |